Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nanotis, a Japan-based infectious disease diagnostics developer spun out of University of Tokyo, has raised a pre-series A round of undisclosed size from pharmaceutical company Taisho Pharmaceutical for research and development for rapid diagnostic devices. The company had secured ¥45m ($402,000) in October 2018 from financial services firm Shizuoka Bank’s Shizuoka Capital unit, light technology developer Hamamatsu Photonics and unnamed private investors.
EneCoat Technologies, a Japan-based perovskite solar cell developer spun out of Kyoto University in 2018, has received…
